Lava Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer (NCT05369000) | Lava Therapeutics | 2022-01-17 |
| Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML (NCT04887259) | Lava Therapeutics | 2021-07-12 |
Track Lava Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.